Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jennifer Ann Brainard, MD, is a Staff Pathologist in the Department of Anatomic Pathology at Cleveland Clinic's main campus. Except for the fellowship in surgical pathology and cytopathology she completed at the Medical College of Virginia Hospitals, Dr. Brainard has spent her entire medical career in the Cleveland Clinic Department of Anatomic Pathology. After completing her residency as chief resident, Dr. Brainard went on staff first as a clinical associate staff pathologist, then as associate pathologist in this department. She is board-certified in cytopathology as well as anatomic and clinical Pathology.
Dr. Brainard's specialty interests include cytopathology, gynecologic pathology and needle aspiration.
She received her medical degree at the Ohio State University College of Medicine before beginning her career at Cleveland Clinic as a resident in anatomic and clinical pathology. She is licensed to practice medicine in Ohio.
Dr. Brainard has published numerous scientific journal articles and abstracts, lectured and participated in scientific platform presentations and faculty workshops. She is a member of the American Society of Clinical Pathologists, both the Virginia and Ohio Societies of Pathology and the American Society of Cytopathology, among others. She is the recipient of the George C. Hoffman Award and the John Beach Hazard Distinguished Teacher Award from Cleveland Clinic’s Division of Pathology and Laboratory Medicine. She is a diplomate of anatomic and clinical Pathology, as well as the subspecialty of cytopathology of the American Board of Pathology.
cytopathology, gynecologic pathology, fine needle aspiration, needle aspiration
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Brainard's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.